Concepedia
Statistics
Publications
9
Citations
885
H-Index
Active since
1915
Affiliations
Novartis (United Kingdom)(Current)
Novartis (United States)
National Jewish Health
Hôpital Arnaud de Villeneuve
University of Colorado Denver
Howard Fox is an author at Novartis (United Kingdom) specializing in medicine, dermatopathology, and dermatology.
Top concepts
MedicineDermatologyDermatopathologyAllergyPathologyImmunologyParasitologyImmunotherapyPeanut AllergyAllergy Medicine
Publications per year
1915–2006
Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma
Jean Bousquet, Sally E. Wenzel, Stephen T. Holgate et al. · CHEST Journal · 2004 · 276 citations
Asthma, Allergy, Allergy Medicine +8
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
Paul Chervinsky, Thomas B. Casale, Robert G. Townley et al. · Annals of Allergy Asthma & Immunology · 2003 · 210 citations
Allergy, Allergy Medicine, Immunology +9
Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma
Günther Hochhaus, L Brookman, Howard Fox et al. · Current Medical Research and Opinion · 2003 · 183 citations
Efficacy of Omalizumab, an Anti-immunoglobulin E Antibody, in Patients with Allergic Asthma at High Risk of Serious Asthma-related Morbidity and Mortality
Stephen T. Holgate, Jean Bousquet, Sally E. Wenzel et al. · Current Medical Research and Opinion · 2001 · 117 citations
Improvement in quality of life with omalizumab in patients with severe allergic asthma
Bradley E. Chipps, Roland Buhl, Kai-Michael Beeh et al. · Current Medical Research and Opinion · 2006 · 46 citations
1–5 of 9